These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4195300)

  • 1. Inactivation of "Arvin" by plasma proteins.
    Pitney WR; Regoeczi E
    Br J Haematol; 1970 Jul; 19(1):67-81. PubMed ID: 4195300
    [No Abstract]   [Full Text] [Related]  

  • 2. Occlusion of plasma proteins by human fibrin: studies using trace-labelled proteins.
    Regoeczi E
    Br J Haematol; 1968 Mar; 14(3):279-90. PubMed ID: 4171294
    [No Abstract]   [Full Text] [Related]  

  • 3. Formation of soluble fibrin polymers. Fibrinogen degradation fragments D and E fail to form soluble complexes with fibrin monomer.
    Smith GF; Bang NU
    Biochemistry; 1972 Aug; 11(16):2958-66. PubMed ID: 4261258
    [No Abstract]   [Full Text] [Related]  

  • 4. The proteolytic action of Arvin on human fibrinogen.
    Ewart MR; Hatton MW; Basford JM; Dodgson KS
    Biochem J; 1970 Jul; 118(4):603-9. PubMed ID: 5529716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of nonfibrin protein in fibrin clots by use of I-131-labeled protein fractions.
    Green GS
    Clin Chem; 1966 Nov; 12(11):808-15. PubMed ID: 4162495
    [No Abstract]   [Full Text] [Related]  

  • 6. Anticoagulants produced by thrombin from fibrin, the effect on blood coagulation, some physical characteristics.
    Muirhead CR; Triantaphyllopoulos DC
    Thromb Diath Haemorrh; 1971 Oct; 26(2):211-23. PubMed ID: 5316291
    [No Abstract]   [Full Text] [Related]  

  • 7. Factors affecting plasma clot absorbance and fibrin mass.
    Rosenfeld L
    Clin Chim Acta; 1967 Oct; 18(1):1-10. PubMed ID: 6064688
    [No Abstract]   [Full Text] [Related]  

  • 8. [EFFECT OF SNAKE VENOMS ON BLOOD COAGULATION IN VITRO].
    KORNALIK F
    Acta Univ Carol Med (Praha); 1963; 9():149-88. PubMed ID: 14166155
    [No Abstract]   [Full Text] [Related]  

  • 9. Organ distribution of fibrin in disseminated intravascular coagulation.
    Regoeczi E; Brain MC
    Br J Haematol; 1969 Jul; 17(1):73-81. PubMed ID: 5807789
    [No Abstract]   [Full Text] [Related]  

  • 10. INTERFERENCE IN LOCALIZATION OF I-131 FIBRINOGEN IN RAT TUMORS BY ANTICOAGULANTS.
    SHAEFFER JR
    Am J Physiol; 1964 Mar; 206():573-9. PubMed ID: 14160987
    [No Abstract]   [Full Text] [Related]  

  • 11. Bovine platelet proteins. I. Soluble proteins studied by immunoelectrophoresis and polyacrylamide disc electrophoresis.
    Lopaciuk S; Solum NO
    Thromb Diath Haemorrh; 1969 Jun; 21(3):409-18. PubMed ID: 4184775
    [No Abstract]   [Full Text] [Related]  

  • 12. Properties of thrombin and fibrinolysin lysed fibrin.
    Triantaphyllopoulos DC; Muirhead CR; Triantaphyllopoulos E
    Thromb Diath Haemorrh Suppl; 1969; 36():269-76. PubMed ID: 5375545
    [No Abstract]   [Full Text] [Related]  

  • 13. QUANTITATIVE DETERMINATION OF 6.6 S GAMMA-GLOBULINS, BETA-2A-GLOBULINS AND GAMMA-1-MACROGLOBULINS IN HUMAN SERUM.
    FAHEY FL; LAWRENCE ME
    J Immunol; 1963 Nov; 91():597-603. PubMed ID: 14089762
    [No Abstract]   [Full Text] [Related]  

  • 14. Interference of lysed fibrin with coagulation: a quantifying approach using isotopic techniques.
    Regoeczi E
    Br J Haematol; 1971 Aug; 21(2):209-18. PubMed ID: 4934606
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of fibrinolytic inhibitors and heparin on induced intravascular coagulation.
    Nordström S
    Acta Physiol Scand Suppl; 1970; 337():1-35. PubMed ID: 5311663
    [No Abstract]   [Full Text] [Related]  

  • 16. Different molecular forms of plasminogen and plasmin produced by urokinase in human plasma and their relation to protease inhibitors and lysis of fibrinogen and fibrin.
    Müllertz S
    Biochem J; 1974 Nov; 143(2):273-83. PubMed ID: 4282470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism and distribution of fibrinogen. I. Fibrinogen turnover in physiological conditions in humans.
    Collen D; Tytgat GN; Claeys H; Piessens R
    Br J Haematol; 1972 Jun; 22(6):681-700. PubMed ID: 5064500
    [No Abstract]   [Full Text] [Related]  

  • 18. On the physiological role of 2 -macroglobulin.
    Rinderknecht H; Geokas MC
    Biochim Biophys Acta; 1973 Jan; 295(1):233-44. PubMed ID: 4346434
    [No Abstract]   [Full Text] [Related]  

  • 19. Soluble unclottable complexes formed in the presence of fibrinogen degradation products (FDP) during the fibrinogen-fibrin conversion and their potential significance in pathology.
    Lipinski B; Wegrzynowicz Z; Budzynski AZ; Kopeć M; Latallo ZS; Kowalski E
    Thromb Diath Haemorrh; 1967 Feb; 17(1-2):65-77. PubMed ID: 5584961
    [No Abstract]   [Full Text] [Related]  

  • 20. [Assay methods and significance of fibrin-fibrinogen degradation products in blood].
    Shinada S
    Nihon Ketsueki Gakkai Zasshi; 1972 Oct; 35(5):607-16. PubMed ID: 4677376
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.